Market revenue in 2020 | USD 13.3 billion |
Market revenue in 2028 | USD 40.1 billion |
Growth rate | 14.8% (CAGR from 2020 to 2028) |
Largest segment | Amplification kits |
Fastest growing segment | Detection Kits |
Historical data covered | 2018 - 2019 |
Base year for estimation | 2020 |
Forecast period covered | 2021 - 2028 |
Quantitative units | Revenue in USD billion |
Market segmentation | Purification Kits, Amplification Kits, Detection Kits, Isolation Kits |
Key market players worldwide | Thermo Fisher Scientific Inc, Qiagen NV, New England Biolabs, Illumina Inc, Agilent Technologies Inc, Bio-Rad Laboratories Inc, Merck KGaA, Promega, Takara Bio Inc, LGC Group, Toyobo Co Ltd |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biotechnology reagents & kits market will help companies and investors design strategic landscapes.
Amplification kits was the largest segment with a revenue share of 23.31% in 2020. Horizon Databook has segmented the Latin America biotechnology reagents & kits market based on purification kits, amplification kits, detection kits, isolation kits covering the revenue growth of each sub-segment from 2018 to 2028.
Latin American biotechnology reagents and kits market is set to grow at a steady pace over the years. This can be attributed to a favorable business environment that aids establishment of new biotech companies and startups in this region.
In addition, market expansion by players from developed economies to Latin American countries is expected to increase competition in the near future. Latin American biotech startups are also growing in the biotech sector at a significant pace.
The key challenge for Latin America in biotech development is the risk of investing in a product that has not been tested in the market. Several drugs and devices must be subjected to tests and clinical trials before being launched in the market, so biotech startups cannot grow without capital.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America biotechnology reagents & kits market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America biotechnology reagents & kits market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account